Alzheimer’s disease (AD) is a multifaceted neurodegenerative disorder driven by amyloid-β (Aβ) plaques, tau neurofibrillary tangles, and chronic neuroinflammation, with the NLRP3 inflammasome playing a central role in disease progression. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.